Humana Inc.

(New York Stock Exchange)
Back to all articles
Slightly Bullish +25

What Humana gave up for a lighter balance sheet | AInvest

Business restructuring Joint venture AI-generated analysis

🏥 Humana sold majority stakes in ~150 senior-care clinics to BlackRock's HPS for $2.8B, removing a $2.8B debt-like obligation from its balance sheet.

📉 The deal cedes the primary upside of cost savings and quality bonuses to BlackRock, leaving Humana with only a minority stake in the CenterWell network.

⭐ Improved Medicare Advantage star ratings (projected 95% at 4+ stars in 2027) could generate $4.8B in quality bonuses by 2028, driving recent stock gains.

📅 BlackRock retains exit options until 2033, allowing it to force a sale if Humana does not repurchase the majority of the clinics.

💰 Humana reaffirmed guidance for at least $9 in adjusted earnings per share for 2026 despite the major asset restructuring.

⚖️ The transaction replaces a previous joint venture with private equity firm WCAS, eliminating a 'put' option that required Humana to buy out its stake.

Bullish Signals
  • Humana removed a $2.8 billion debt-like obligation from its balance sheet by selling majority stakes in its CenterWell clinic network.
  • The company reaffirmed guidance for at least $9 in adjusted earnings per share for 2026 following the restructuring announcement.
  • Improved Medicare Advantage star ratings, with 95% of members projected to achieve 4+ stars in 2027, could generate approximately $4.8 billion in quality bonuses by 2028.
Risk Factors
  • By selling majority stakes, Humana has ceded the primary economic upside from cost savings and quality bonuses to BlackRock, which now holds majority ownership.
  • The deal structure allows BlackRock to force a sale of the remaining clinics by 2033 if Humana fails to repurchase them, creating long-term asset uncertainty.
  • The long-term success of the transaction depends entirely on whether Humana can sustainably control medical costs below Medicare payments, as it no longer owns the majority of the delivery network.
Full Analysis
Humana announced a major restructuring of its CenterWell senior-care clinic network, selling majority stakes in approximately 150 clinics to HPS Investment Partners, a subsidiary of BlackRock, for $2.8 billion. The deal is expected to close in the fourth quarter and replaces a previous joint venture with private equity firm WCAS that carried a $2.8 billion debt-like obligation known as a 'put'. By removing this liability, Humana aims to improve its balance sheet, lower its cost of capital, and free up resources for growth investments within the remaining network. The transaction fundamentally alters the economic upside associated with Humana's high-quality care model. While Humana retains operational control and a minority stake in the clinics, it has ceded majority ownership rights to BlackRock. This structure means that future cost savings generated by keeping patients healthy—specifically the difference between Medicare payments and actual medical costs—will accrue primarily to BlackRock rather than Humana. The deal includes an exit option for BlackRock until 2033, allowing them to force a sale if Humana does not repurchase the assets. Humana's recent stock surge is driven less by this transaction and more by improved Medicare Advantage star ratings. The company projects that 95% of its members will achieve four or more stars in 2027, up from 20% in 2026, which could generate approximately $4.8 billion in quality bonuses by 2028. However, the long-term viability of this strategy hinges on whether Humana can sustainably control medical costs below Medicare reimbursement rates. If successful, the asset may be worth more than the sale price; if not, the deal represents a significant discount for BlackRock. The company reaffirmed its guidance for at least $9 in adjusted earnings per share for 2026 despite the restructuring. The strategic implication is that Humana has effectively offloaded the primary engine of its value creation—the CenterWell network—to a patient capital provider like BlackRock. The success of this move depends entirely on the trajectory of Medicare Advantage margins and Humana's ability to maintain profitability without majority ownership of the clinics it operates.